Company intelligence
As of September 22, 2026, Heidi Health was last valued at $900M (September 2026 Series C) and has raised at least $405M in equity across 2 sourced funding rounds.
Heidi is a Melbourne-based company whose AI software records medical appointments and produces structured documents for clinicians to review.[1] Heidi says its product has supported more than 175 million patient visits.[2] It handles about 2.8 million patient interactions a week across 110 languages and 190 countries.[2] In the U.K. it is the sole supplier to NHS England Midlands.[2] In New Zealand it runs in every emergency department in the country.[2] Its U.S. users include Beth Israel Lahey Health in Massachusetts.[2] Heidi employs close to 600 people.[2] Kelly said the money will fund a move from documentation to agents that handle clinical work under supervision.[2]
Annual recurring revenue grew from US$1 million to US$50 million in two years, reaching that level in April 2026.[2]
Is something wrong on this page?
| Date | Round | Amount | Valuation | Lead investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2026 | Series C | $340M | $900Mpost-money | Blackbird Venturesunverified | PYMNTS |
| Oct 2025 | Series B | $65M | — | Point72unverified | thenextweb.com |
Equity only. “Equity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.
Point72 led a US$65 million Series B in October 2025 at a US$465 million valuation.[2] In September 2026 Heidi announced US$340 million in new funding in two parts.[2] Blackbird, an investor since the 2021 pre-seed, led a US$100 million Series C at a US$900 million valuation, with Phoenix Court, Point72 Private Investments and Headline participating.[2] Heidi has raised US$436.6 million in total.[2]
Heidi has raised US$436.6 million in total.[2]
Annual recurring revenue grew from US$1 million to US$50 million in two years, reaching that level in April 2026.[2]
Blackbird, an investor since the 2021 pre-seed, led a US$100 million Series C at a US$900 million valuation, with Phoenix Court, Point72 Private Investments and Headline participating.[2]
Heidi Health was co-founded in 2021 by Dr. Thomas Kelly, its CEO, with Waleed Mussa and Yu Liu.[1]
Heidi is a Melbourne-based company whose AI software records medical appointments and produces structured documents for clinicians to review.[1]
Heidi Health was last valued at $900M in its September 2026 Series C, according to PYMNTS (September 22, 2026).
Heidi Health is headquartered in Melbourne, Australia, according to Wikidata.
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.